Immunotherapy. 2011;3(9):1075-1086. MIP-1β release has also been observed for CD56 neg NK cells from patients with HCV infection. The above results suggest that the aberrant CD56 neg NK subset ...

A T cell, for instance, has a lock-shaped structure on its surface into which ... cells from AML patients than NK cells that either only carried the CAR receptor or lacked the immune checkpoint ...

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...

Triggering receptors expressed on myeloid cells (TREMs) are a cell surface receptor family found on granulocytes, monocytes, macrophages, and dendritic cells—as well as other myeloid cells in general.

"This strategy is also applicable to NK cells generated through different protocols, including those expressing chimeric antigen receptors (CAR), which allows recognizing specific antigens found ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

But T-cells aren't the only option for cell therapy. Promising work is being done with natural killer, or NK cells, a different kind of immune system cell that could work even better in some ways.

T cells are white blood cells that are important for adaptive immunity. They have unique cell surface receptors that ... organs and find B, T and NK cells and exhausted memory CD4 T cells ...